Bonjour, ceci est un commentaire. Pour supprimer un commentaire, connectez-vous et affichez les commentaires de cet article. Vous pourrez alors…
Weinberg, R.A. (2007) The Biology of Cancer. 1st Edition, Garland Science, New York.
- Listed: 12 June 2026 13 h 16 min
Description
Weinberg, R.A. (2007) The Biology of Cancer. 1st Edition, Garland Science, New York.
“Weinberg, R.A. (2007) The Biology of Cancer. 1st Edition, Garland Science, New York.”
The field of cancer research has experienced tremendous growth and advancements in recent years, thanks to the contributions of renowned scientists like Robert A. Weinberg. In his seminal book, “The Biology of Cancer,” published in 2007 by Garland Science, New York, Weinberg provides a comprehensive overview of the complex biological processes that underlie the development and progression of cancer. This groundbreaking publication has become a cornerstone of cancer research, shedding light on the molecular mechanisms that drive tumor formation and metastasis. By understanding the biology of cancer, researchers and clinicians can develop more effective strategies for cancer prevention, diagnosis, and treatment, ultimately improving patient outcomes and saving lives.
One of the key aspects of Weinberg’s book is its focus on the genetic and epigenetic alterations that occur in cancer cells. These changes can disrupt normal cellular function, leading to uncontrolled cell growth, invasion, and metastasis. The book delves into the various types of genetic mutations that can contribute to cancer, including point mutations, chromosomal translocations, and gene amplifications. Additionally, it explores the role of epigenetic modifications, such as DNA methylation and histone modification, in regulating gene expression and promoting tumor development. By elucidating the molecular mechanisms that drive cancer, researchers can identify potential targets for therapy, including oncogenes, tumor suppressor genes, and signaling pathways.
Weinberg’s work has also highlighted the importance of the tumor microenvironment in cancer progression. The tumor microenvironment consists of a complex network of cells, including cancer cells, stromal cells, and immune cells, which interact and influence one another. This dynamic interplay can promote or inhibit tumor growth, depending on the specific context. The book discusses the various ways in which the tumor microenvironment can contribute to cancer development, including the recruitment of blood vessels, the suppression of anti-tumor immune responses, and the modulation of signaling pathways. By understanding the interplay between cancer cells and their microenvironment, researchers can develop more effective therapies that target not only the cancer cells themselves but also the surrounding tissue.
The publication of “The Biology of Cancer” has had a significant impact on the field of cancer research, inspiring new areas of investigation and influencing the development of innovative therapies. The book’s emphasis on the molecular and cellular mechanisms of cancer has led to a greater understanding of the disease, enabling researchers to design more targeted and effective treatments. Furthermore, the book’s discussion of the tumor microenvironment has highlighted the importance of considering the complex interactions between cancer cells and their surroundings. As researchers continue to build upon Weinberg’s work, we can expect to see new breakthroughs in cancer diagnosis, treatment, and prevention, ultimately improving the lives of patients and families affected by this devastating disease. By supporting cancer research and education, we can work towards a future where cancer is no longer a life-threatening illness, but a manageable and curable condition.
28 total views, 1 today
Sponsored Links
D. Abernethy, M. Divoll and D. Greenblatt, “Obesity, Sex, and Acetaminophen...
D. Abernethy, M. Divoll and D. Greenblatt, “Obesity, Sex, and Acetaminophen Disposition,” Clinical Pharmacology and Therapeutics, Vol. 31, 1982, pp. 783-790. doi:10.1038/clpt.1982.111 None
No views yet
T. Walle, R. P. Byington, C. D. Furberg, et al., “Biologic Determinants of ...
T. Walle, R. P. Byington, C. D. Furberg, et al., “Biologic Determinants of Propranolol Disposition: Results from 1308 Patients in the Beta-Blocker Heart Attack Trial,” […]
No views yet
S. L. Miaskiewicz, C. A. Shively and E. S. Vesell, “Sex Differences in Abso...
S. L. Miaskiewicz, C. A. Shively and E. S. Vesell, “Sex Differences in Absorption Kinetics of Sodium Salicylate,” Clinical Pharmacology and Therapeutics, Vol. 31, No. […]
No views yet
C. J. Timmer, J. M. Sitsen and L. P. Delbressine, “Clinical Pharmacokinetic...
C. J. Timmer, J. M. Sitsen and L. P. Delbressine, “Clinical Pharmacokinetics of Mirtazapine,” Clinical Pharmacokinetics, Vol. 38, No. 6, 2000, pp. 461-474. doi:10.2165/00003088-200038060-00001 None
1 total views, 1 today
W. Aichhorn, M. Gasser, E. M. Weiss, et al., “Gender Differences in Pharmac...
W. Aichhorn, M. Gasser, E. M. Weiss, et al., “Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs,” Current Neuropharmacology, Vol. 3, […]
No views yet
M. N. Martinez and G. L. Amidon, “A Mechanistic Approach to Understanding t...
M. N. Martinez and G. L. Amidon, “A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals,” Journal of Clinical Pharmacology, […]
1 total views, 1 today
M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of Gender-Specific Medic...
M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of Gender-Specific Medicine, Vol. 2, 1999, pp. 18-20. **M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of […]
No views yet
J. C. Kando, K. A. Yonkers and J. O. Cole, “Gender as a Risk Factor for Adv...
J. C. Kando, K. A. Yonkers and J. O. Cole, “Gender as a Risk Factor for Adverse Events to Medications,” Drugs, Vol. 50, No. 1, […]
1 total views, 1 today
L. T. Khon, “Organizing and Managing Care in a Changing Health System,” Hea...
L. T. Khon, “Organizing and Managing Care in a Changing Health System,” Health Service Research, Vol. 35, No. 1, 2000, pp. 37-52. None
No views yet
D. Abernethy, M. Divoll and D. Greenblatt, “Obesity, Sex, and Acetaminophen...
D. Abernethy, M. Divoll and D. Greenblatt, “Obesity, Sex, and Acetaminophen Disposition,” Clinical Pharmacology and Therapeutics, Vol. 31, 1982, pp. 783-790. doi:10.1038/clpt.1982.111 None
No views yet
T. Walle, R. P. Byington, C. D. Furberg, et al., “Biologic Determinants of ...
T. Walle, R. P. Byington, C. D. Furberg, et al., “Biologic Determinants of Propranolol Disposition: Results from 1308 Patients in the Beta-Blocker Heart Attack Trial,” […]
No views yet
S. L. Miaskiewicz, C. A. Shively and E. S. Vesell, “Sex Differences in Abso...
S. L. Miaskiewicz, C. A. Shively and E. S. Vesell, “Sex Differences in Absorption Kinetics of Sodium Salicylate,” Clinical Pharmacology and Therapeutics, Vol. 31, No. […]
No views yet
C. J. Timmer, J. M. Sitsen and L. P. Delbressine, “Clinical Pharmacokinetic...
C. J. Timmer, J. M. Sitsen and L. P. Delbressine, “Clinical Pharmacokinetics of Mirtazapine,” Clinical Pharmacokinetics, Vol. 38, No. 6, 2000, pp. 461-474. doi:10.2165/00003088-200038060-00001 None
1 total views, 1 today
W. Aichhorn, M. Gasser, E. M. Weiss, et al., “Gender Differences in Pharmac...
W. Aichhorn, M. Gasser, E. M. Weiss, et al., “Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs,” Current Neuropharmacology, Vol. 3, […]
No views yet
M. N. Martinez and G. L. Amidon, “A Mechanistic Approach to Understanding t...
M. N. Martinez and G. L. Amidon, “A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals,” Journal of Clinical Pharmacology, […]
1 total views, 1 today
M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of Gender-Specific Medic...
M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of Gender-Specific Medicine, Vol. 2, 1999, pp. 18-20. **M. J. Berg, “Drugs, Vitamins, and Gender,” Journal of […]
No views yet
J. C. Kando, K. A. Yonkers and J. O. Cole, “Gender as a Risk Factor for Adv...
J. C. Kando, K. A. Yonkers and J. O. Cole, “Gender as a Risk Factor for Adverse Events to Medications,” Drugs, Vol. 50, No. 1, […]
1 total views, 1 today
L. T. Khon, “Organizing and Managing Care in a Changing Health System,” Hea...
L. T. Khon, “Organizing and Managing Care in a Changing Health System,” Health Service Research, Vol. 35, No. 1, 2000, pp. 37-52. None
No views yet
Recent Comments